
Pfizer Inc (NYSE:PFE) and BioNTech SE (NASDAQ:BNTX) are likely to submit a request for an emergency use authorization to the U.S. Food and Drug Administration on Tuesday for a COVID-19 vaccine aimed at children younger than five years.
What Happened: The vaccine, made by the two companies, will be the first such available for that particular age group, according to a Washington Post report.